Lack of efficacy (bacteria) - Ehrlichia

Verify with FDA CVM →

VeDDRA Code: 2805

2,539 adverse event reports referencing this reaction

2,539
Total Reports
21
Deaths
80.0%
Death Rate

Species Most Affected

Dog 2,535
Cat 3
Horse 1

Breeds Most Affected

Retriever - Labrador 348
Crossbred Canine/dog 273
Dog (unknown) 200
Retriever - Golden 188
Shepherd Dog - German 177
Shepherd Dog - Australian 106
Beagle 71
Great Pyrenees 59
Terrier (unspecified) 47
Collie - Border 43

Associated Drugs

Pyrantel Pamoate;Sarolaner 1,095
Afoxolaner 596
Fluralaner 13.64% 12-Week Chew 522
Sarolaner 141
Lotilaner 135
Ivermectin + Pyrantel As Pamoate Salt 64
Milbemycin Oxime + Praziquantel 59
Fluralaner 5.46% 1-Month Chew 56
Afoxolaner 150Mg / Moxidectin 720Mcg / Pyrantel 300Mg Chewable Tablet 38
Afoxolaner 75Mg / Moxidectin 360Mcg / Pyrantel 150Mg Chewable Tablet 26
Recombinant E. Coli Bl21;Recombinant E. Coli Ecl19 22
Recombinant E. Coli Bl21;Recombinant E. Coli Ecl19 18
Milbemycin/Lufenuron/Pzq Chew 15
Afoxolaner 37.5Mg / Moxidectin 180Mcg / Pyrantel 75Mg Chewable Tablet 15
Recombitek Lyme - 2126.R0 13
Borrelia Burgdorferi Bacterin-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract 11
Fluralaner Spot-On Solution 11
Doxycycline 9
Afoxolaner 18.75Mg / Moxidectin 90Mcg / Pyrantel 37.5Mg Chewable Tablet 9
Fluralaner 8

Data Summary

Metric Value
Total reports referencing reaction 2,539
Reports with fatal outcome 21
Case-fatality rate (reported events) 80.0%
Species observed 3
Breeds observed 20
Drugs associated with reaction 20

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER); reaction term coded under VeDDRA 2805.

Lack of efficacy (bacteria) - Ehrlichia Reaction Insights

The FDA Center for Veterinary Medicine database currently lists 2,539 adverse event reports that reference Lack of efficacy (bacteria) - Ehrlichia as a reaction term, including 21 reports with a death outcome — a 80.0% case-fatality figure calculated across only those events where this reaction was coded. The reaction is indexed in the openFDA system under VeDDRA code 2805, the standardized veterinary dictionary used to normalize clinical signs across submitters. Because reports are voluntary and often describe multiple concurrent signs per animal, the volume here reflects reporting intensity rather than true incidence in the broader pet population.

Lack of efficacy (bacteria) - Ehrlichia appears most frequently in reports for Dog (2,535 reports), Cat (3 reports), Horse (1 reports) — with Dog dominating at 2,535 entries. Within those species, the breeds most often named alongside this reaction are Retriever - Labrador (348), Crossbred Canine/dog (273), Dog (unknown) (200). These distributions are influenced both by underlying breed popularity and by how veterinarians and owners code a given clinical sign, so they should be interpreted as a reporting fingerprint rather than a pure susceptibility ranking.

The drugs most commonly co-reported with Lack of efficacy (bacteria) - Ehrlichia are Pyrantel Pamoate;Sarolaner (1,095 reports), Afoxolaner (596 reports), Fluralaner 13.64% 12-Week Chew (522 reports), Sarolaner (141 reports), with Pyrantel Pamoate;Sarolaner appearing alongside this reaction in 1,095 submissions. Co-reporting does not establish that any specific product caused the reaction — FDA CVM data captures temporal association only. The value of these aggregates is in flagging which therapeutic classes appear repeatedly alongside a given clinical sign, so owners and veterinarians can ask targeted questions about medications currently in use.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial